Ceruloplasmin, another acute-phase protein produced in the liver that plays a role in copper metabolism and may have a role in the pathogenesis of metabolic diseases such as type 2 diabetes [18], decreased significantly in the semaglutide group but not in the empagliflozin group (Table 1, Figure 2D). This evidence concerns the gene CP and metabolic disease.